(Press-News.org) ANN ARBOR, Mich. — The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful tingling feelings caused by chemotherapy in 59 percent of patients, a new study finds. This is the first clinical trial to find an effective treatment for this pain.
Chemotherapy-induced peripheral neuropathy is a common side effect of certain chemotherapy drugs. The tingling feeling -- usually felt in the toes, feet, fingers and hands -- can be uncomfortable for many patients, but for about 30 percent of patients, it's a painful sensation. Previous studies have found no reliable way to treat this type of pain.
In the current study, which will be presented Tuesday at the American Society of Clinical Oncology Annual Meeting, researchers looked at 231 patients who reported painful neuropathy after receiving the chemotherapy drugs oxaliplatin or paclitaxel. Patients were randomly assigned to receive duloxetine or a placebo for five weeks. They were asked to report on their pain levels weekly throughout the study.
The researchers found that 59 percent of patients who received duloxetine reported reduced pain, while only 39 percent of those taking placebo did.
"These drugs don't work in everyone. The good news is it worked in the majority of patients. We need to figure out who are the responders. If we can predict who they are, we can target the treatment to the people it's going to work for," said lead study author Ellen M. Lavoie Smith, Ph.D., APRN, AOCN, assistant professor at the University of Michigan School of Nursing and a researcher at the U-M Comprehensive Cancer Center.
Duloxetine has previously been shown to help relieve painful diabetic neuropathy. This type of antidepressant is believed to work on pain by increasing neurotransmitters that interrupt pain signals to the brain.
In this study, participants received a half dose of duloxetine – 30 milligrams a day - the first week before ramping up to a full dose of 60 mg daily for four more weeks. Few severe side effects were reported with this approach. The most common side effect was fatigue.
Treating painful peripheral neuropathy is critical because the condition can lead doctors to limit the patient's chemotherapy dose if the pain becomes too severe.
"In addition to improving symptoms and quality of life, treating peripheral neuropathy pain potentially improves quantity of life if it helps patients avoid decreasing their chemotherapy medications," Smith says.
Often, Smith adds, patients avoid telling their doctors about pain because they do not want their chemotherapy dose decreased.
"Patients make this trade-off sometimes: They don't want to give up the chemotherapy and decide they'd rather have this pain. That's a terrible trade off to make," Smith says.
The researchers' next steps are to determine which patients are most likely to benefit from duloxetine.
###
Additional authors: Herbert Pang, Ph.D.; Constance Cirrincione, M.S.; Stewart Fleishman, M.D.; Electra D. Paskett, Ph.D.; Tim Ahles, Ph.D.; Camilo Fadul, M.D.; Chetaye Knox; Charles L. Shapiro, M.D.
Funding: National Institutes of Health's National Cancer Institute; drugs and placebo provided by Lilly Pharmaceuticals
Disclosure: None
Reference: "CRA9013: CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN)," Smith et al. American Society of Clinical Oncology Annual Meeting, June 1-5, 2012
Resources:
U-M Cancer AnswerLine, 800-865-1125
U-M Comprehensive Cancer Center, www.mcancer.org
U-M School of Nursing, www.nursing.umich.edu
Clinical trials at U-M, www.UMClinicalStudies.org/cancer
For more information, contact:
Nicole Fawcett, nfawcett@umich.edu, 734-764-2220
Heidi Watson, watsonh@umich.edu, 734-615-7125
END
Pittsburgh, PA…An international team of researchers has announced the discovery of Afrasia djijidae, a new fossil primate from Myanmar that illuminates a critical step in the evolution of early anthropoids—the group that includes humans, apes, and monkeys. The 37-million-year-old Afrasia closely resembles another early anthropoid, Afrotarsius libycus, recently discovered at a site of similar age in the Sahara Desert of Libya. The close similarity between Afrasia and Afrotarsius indicates that early anthropoids colonized Africa only shortly before the time when these animals ...
COLUMBUS, Ohio - Skin cancer patients whose childhood included periods of neglect or maltreatment are at a much greater risk for their cancers to return when they face a major stressful event, based on a new study.
The research suggests that such experiences during a person's youth can set a lower level of immune response for life, which in turn might make them more susceptible to the kind of cancers that are often successfully fought by the immune system, so-called immunogenic tumors.
While the research focused on patients with a fairly benign form of skin cancer -- ...
ROCHESTER, Minn. -- High doses of the herb American ginseng (Panax quinquefolius) over two months reduced cancer-related fatigue in patients more effectively than a placebo, a Mayo Clinic-led study found. Sixty percent of patients studied had breast cancer. The findings are being presented at the American Society of Clinical Oncology's annual meeting.
Researchers studied 340 patients who had completed cancer treatment or were being treated for cancer at one of 40 community medical centers. Each day, participants received a placebo or 2,000 milligrams of ginseng administered ...
STANFORD, Calif. — In a new study of the effects of soy supplements for postmenopausal women, researchers at the Stanford University School of Medicine and the USC Keck School of Medicine found no significant differences — positive or negative — in overall mental abilities between those who took supplements and those who didn't.
While questions have swirled for years around a possible link between soy consumption and changes in cognition, this research offers no evidence to support such claims. "There were no large effects on overall cognition one way or another," said ...
North Carolina's coordinated, regional systems for rapid care improved survival rates of patients suffering from the most severe heart attack, according to research in the American Heart Association's journal, Circulation.
Fewer ST -segment elevation myocardial infarction (STEMI) patients died when paramedics diagnosed them en route to hospitals and hospitals followed well-defined guidelines to quickly treat or transfer patients to facilities that performed artery-opening procedures, if needed. Death rates were 2.2 percent for patients treated to guideline standards and ...
San Antonio, Texas, June 4, 2012 – Prisoners need education on the appropriate use of topical antibiotic products, according to a study released today at the 39th Annual Educational Conference and International Meeting of the Association for Professionals in Infection Control and Epidemiology (APIC).
The first study to report on the widespread misuse of topical antibiotics among inmates entering prisons from other correctional facilities found that, among inmates who reported having used topical antibiotics during the previous six months, 59 percent of male and 40 percent ...
CHICAGO – A 38-year longitudinal study of New Zealanders suggests that individuals with higher genetic risk scores were more likely to be chronically obese in adulthood, according to a report published in the June issue of Archives of Pediatrics & Adolescent Medicine, a JAMA Network publication.
Obesity is capable of being inherited and genome-wide association studies (GWASs) have started to uncover the molecular roots of heritability by identifying multiple single-nucleotide polymorphisms (SNPs) associated with higher adult body mass index (BMI), the authors write in ...
San Antonio, Texas, June 4, 2012 – Preventing further complications in patients who develop infections after surgery to replace a knee or hip could save the U.S. healthcare system as much as $65 million annually, according to an analysis presented today at the 39th Annual Educational Conference and International Meeting of the Association for Professionals in Infection Control and Epidemiology (APIC).
The research team, led by Keith Kaye, MD, MPH, corporate director of Infection Prevention, Hospital Epidemiology and Antimicrobial Stewardship at Detroit Medical Center/Wayne ...
Scientists have shown that the brains of people with depression respond differently to feelings of guilt – even after their symptoms have subsided.
University of Manchester researchers found that the brain scans of people with a history of depression differed in the regions associated with guilt and knowledge of socially acceptable behaviour from individuals who never get depressed.
The study – published in the journal Archives of General Psychiatry – provides the first evidence of brain mechanisms to explain Freud's classical observation that exaggerated guilt and ...
DURHAM, N.C.— An ambitious effort to coordinate heart attack care among every hospital and emergency service in North Carolina improved patient survival rates and reduced the time from diagnosis to treatment, according to Duke University Medical Center researchers who spearheaded the program.
"When treating heart attacks, the most important care decisions need to take place before the patient is brought to the hospital," says James Jollis, M.D., a Duke cardiologist and first author of the findings published today in the journal Circulation. "These procedures should be ...
